Latest Investments News

Fortescue Metals Group kicked off FY26 with record iron ore shipments and strengthened its decarbonisation strategy through new partnerships and a $2 billion Renminbi loan.

Insignia Financial reported a 3.1% rise in Funds Under Management and Administration to $340.5 billion, driven by strong net inflows into its Wrap platform and strategic enhancements to its MLC offerings. The company also completed a key custody transition and unveiled a refreshed MLC brand campaign.

Audeara Ltd has reported a remarkable 111% revenue increase in Q1 FY26, driven by strong growth in its technology division and key international partnerships in China and Japan. The company is advancing towards cashflow breakeven with improved cash management and expanding global reach.

Insurance Australia Group (IAG) has upgraded its FY26 financial guidance following the acquisition of RACQ’s insurance business, projecting stronger premium growth and higher profits.

Firebrick Pharma reports a $1.94 million cash reserve after a $1.4 million placement, supporting expanded Nasodine sales across Southeast Asia and the US. Board changes and increased operational costs mark a pivotal quarter for the pharmaceutical innovator.

VRX Silica Limited has secured four binding offtake contracts for 410,000 tonnes per annum of silica sand from its Arrowsmith North project, representing nearly half of its initial production capacity and marking a significant commercial milestone.

Cochlear Limited reports steady FY25 financials alongside the launch of its innovative Nucleus Nexa cochlear implant system, setting the stage for projected double-digit profit growth in FY26.

Altitude Minerals has kicked off detailed field activities at its newly acquired Firenze Silver & Gold Project in Nevada, setting the stage for drill testing in early 2026. The project’s promising high-grade silver and gold veins, combined with strategic location and advanced geophysical surveys, highlight its exploration potential.

Agrimin Limited has decided to withdraw from its Mackay Potash Project after a strategic review highlighted challenging market conditions and prohibitive holding costs. The company will now focus on other mineral opportunities in Western Australia.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Alcoa Corporation reported a $232 million net income in Q3 2025 despite significant restructuring costs, driven by increased alumina and aluminum production and strategic asset sales.

Vault Minerals delivered a strong September quarter with record gold production and advancing key infrastructure upgrades, setting the stage for significant free cash flow growth in FY27.